Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].

What problem does this paper attempt to address?

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression

Kun Xu,Shenghui Sun,Mingjing Yan,Ju Cui,Yao Yang,Wenlin Li,Xiuqing Huang,Lin Dou,Beidong Chen,Weiqing Tang,Ming Lan,Jian Li,Tao Shen

DOI: https://doi.org/10.3389/fonc.2023.1204712

IF: 4.7

2023-06-02

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.943032.].

oncology
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Yongmeng Li,Yanfei Liu,Kai Jin,Rui Dong,Cun Gao,Libo Si,Zitong Feng,Huiying Zhang,Hui Tian

DOI: https://doi.org/10.3389/fcell.2022.870313

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.771824.].
Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Yihui Zhou,Xiaomeng Gao,Yuan Meng,Bo Yang,Qiaojun He,Ji Cao

DOI: https://doi.org/10.3389/fphar.2021.785732

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.748852.].
Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian,Meimei Zhao,Qinghua Han,Jingkang Wang,Lixi Liao,Heng Yang,Dan Liu,Pengfei Tu,Hong Liang,Kewu Zeng

DOI: https://doi.org/10.1016/j.apsb.2024.02.013

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.01.011.].
Erratum: Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760].

Minyang Fu,Dandan Peng,Tianxia Lan,Yuquan Wei,Xiawei Wei

DOI: https://doi.org/10.1016/j.apsb.2022.09.013

2022-01-01

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.01.007.].
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum to “Novel biallelic TRNT1 mutations lead to atypical SIFD and multiple immune defects” [Genes Dis 7 (1) (2020) 128–137]

Lu Yang,Xiuhong Xue,Ting Zeng,Xuemei Chen,Qin Zhao,Xuemei Tang,Jun Yang,Yunfei An,Xiaodong Zhao

DOI: https://doi.org/10.1016/j.gendis.2020.04.005

2020-09-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.01.005.].

genetics & heredity,biochemistry & molecular biology
Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer

Xing Bian,Xiaolin Wang,Qiuyan Zhang,Liying Ma,Guozhen Cao,Ao Xu,Jinhua Han,Jun Huang,Wenchu Lin

DOI: https://doi.org/10.3389/fonc.2023.1192526

IF: 4.7

2023-04-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.565820.].

oncology
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Xuan Yang,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mengting Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

Haibin Jiang,Mengyan Tang,Zidi Xu,Yanan Wang,Mopu Li,Shuyin Zheng,Jianghu Zhu,Zhenlang Lin,Min Zhang

DOI: https://doi.org/10.1016/j.gendis.2024.101392

2024-08-19

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2023.03.017.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Hong-guang Wang,Hua Yan,Chen Wang,Mi-mi Li,Xin-ze Lv,Hai-dong Wu,Zhan-hai Fang,Dong-li Mo,Zhi-yuan Zhang,Bin Liang,Ke-guan Lai,Jing-yu Bao,Xue-jia Yang,Hong-juan Zhao,Shuang Chen,Yi-mu Fan,Xiao-guang Tong

DOI: https://doi.org/10.3389/fphys.2022.881750

IF: 4

2022-07-22

Frontiers in Physiology

Abstract:[This corrects the article DOI: 10.3389/fphys.2020.00899.].

physiology
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Xueyao Yang,Jinfan Tian,Lijun Zhang,Wei Dong,Hongzhi Mi,Jianan Li,Jiahui Li,Ye Han,Huijuan Zuo,Jing An,Yi He,Xiantao Song

DOI: https://doi.org/10.3389/fcvm.2022.877972

IF: 3.6

2022-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.754826.].
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Jun Qian,Yanhua Gao,Yan Lai,Zi Ye,Yian Yao,Keke Ding,Jing Tong,Hao Lin,Guoqi Zhu,Yunan Yu,Haoran Ding,Deqiang Yuan,Jiapeng Chu,Fei Chen,Xuebo Liu

DOI: https://doi.org/10.3389/fimmu.2024.1462970

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.908815.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Erratum: Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760].

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum to “Novel biallelic TRNT1 mutations lead to atypical SIFD and multiple immune defects” [Genes Dis 7 (1) (2020) 128–137]

Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis